Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
67.065,53
-0,02%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avadel Pharmaceuticals PLC (AVDL) Avadel Pharmaceuticals PLC (AVDL) Notizie

AVDL

Avadel Pharmaceuticals (AVDL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVDL
DataOraFonteTitoloSimboloCompagnia
17/05/202422:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202422:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202422:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202415:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202414:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
01/05/202414:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
01/04/202414:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
05/03/202414:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202421:37GlobeNewswire Inc.Avadel Pharmaceuticals Issues Statement On Patent LitigationNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202412:30GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202412:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
26/02/202414:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4NASDAQ:AVDLAvadel Pharmaceuticals PLC
14/02/202413:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
13/02/202415:40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVDLAvadel Pharmaceuticals PLC
07/02/202414:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/01/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial HighlightsNASDAQ:AVDLAvadel Pharmaceuticals PLC
28/12/202320:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/11/202313:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
30/10/202313:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter Financial Results on November 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
20/10/202314:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Data Supporting Clinical Profile for LUMRYZ™ (sodium oxybate) for extended-release oral suspension (CIII) at World Sleep 2023NASDAQ:AVDLAvadel Pharmaceuticals PLC
05/10/202314:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:AVDLAvadel Pharmaceuticals PLC
09/08/202313:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
03/08/202322:05GlobeNewswire Inc.Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AVDLAvadel Pharmaceuticals PLC
02/08/202314:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter Financial Results on August 9NASDAQ:AVDLAvadel Pharmaceuticals PLC
23/06/202321:05Dow Jones NewsAvadel Pharmaceuticals to Intervene in Jazz Pharmaceuticals Lawsuit Over FDA RulingNASDAQ:AVDLAvadel Pharmaceuticals PLC
23/06/202318:12Dow Jones NewsAvadel ADRs Tumble 14% Following Lawsuit Trying to Overturn FDA Approval of Similar DrugNASDAQ:AVDLAvadel Pharmaceuticals PLC
23/06/202300:59Dow Jones NewsJazz Pharmaceuticals Files Complaint Against FDA for Decision on Avadel Pharmaceuticals' LumryzNASDAQ:AVDLAvadel Pharmaceuticals PLC
22/06/202314:00GlobeNewswire Inc.Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIIINASDAQ:AVDLAvadel Pharmaceuticals PLC
14/06/202314:00GlobeNewswire Inc.Avadel Pharmaceuticals Sponsors the Academy of Sleep Medicine Foundation’s 2023 Young Investigators Research ForumNASDAQ:AVDLAvadel Pharmaceuticals PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVDL

La tua Cronologia

BIT
F15125
Vontobel Financial Produ...
BIT
O8JN32
MORGAN STANLEY BV
USOTC
EPGNY
Epigenomics (QX)
IDCM
RISEETH
RISE
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network